METHOD FOR ENCODING BROADCAST CHANNEL PROTOCOL DATA UNIT BASED ON BROADCAST CONTROL CHANNEL SCHEDULING ERROR IN UNIVERSAL MOBILE TELECOMMUNICATIONS SYSTEM
    1.
    发明申请
    METHOD FOR ENCODING BROADCAST CHANNEL PROTOCOL DATA UNIT BASED ON BROADCAST CONTROL CHANNEL SCHEDULING ERROR IN UNIVERSAL MOBILE TELECOMMUNICATIONS SYSTEM 有权
    基于通用移动通信系统中广播控制信道调度错误的广播通道协议数据单元编码方法

    公开(公告)号:US20080137637A1

    公开(公告)日:2008-06-12

    申请号:US11828105

    申请日:2007-07-25

    IPC分类号: H04J3/24

    CPC分类号: H04W48/12

    摘要: A method for encoding a broadcast channel protocol data unit (BCH PDU) based on a broadcast control channel (BCCH) scheduling error in a universal mobile telecommunications system (UMTS) having a Node B and a radio network controller includes setting up a call between the radio network controller and the Node B to receive system information and scheduling information for a system information update from the radio network controller; initializing broadcast channel protocol data units and control information for every system frame number (SFN) at the Node B; and detecting the broadcast control channel scheduling error on the scheduling information for the system information update based on segment types of the system information when combining the system information for every system frame number. In case the broadcast control channel scheduling error is not detected, the broadcast channel protocol data units are encoded to be incorporated therein the system information.

    摘要翻译: 在具有节点B和无线网络控制器的通用移动通信系统(UMTS)中,基于广播控制信道(BCCH)调度误差对广播信道协议数据单元(BCH PDU)进行编码的方法包括: 无线电网络控制器和节点B从无线电网络控制器接收用于系统信息更新的系统信息和调度信息; 对节点B的每个系统帧号(SFN)初始化广播信道协议数据单元和控制信息; 以及当对于每个系统帧号组合系统信息时,基于系统信息的段类型来检测用于系统信息更新的调度信息的广播控制信道调度误差。 在没有检测到广播控制信道调度错误的情况下,广播信道协议数据单元被编码为并入其中的系统信息。

    APPARATUS FOR SCHEDULING TRANSMISSION OF DATA UNIT IN BASE STATION
    2.
    发明申请
    APPARATUS FOR SCHEDULING TRANSMISSION OF DATA UNIT IN BASE STATION 有权
    调度基站数据单元传输的装置

    公开(公告)号:US20090147747A1

    公开(公告)日:2009-06-11

    申请号:US12329424

    申请日:2008-12-05

    IPC分类号: H04W72/04

    摘要: The present invention relates to a scheduling apparatus of a base station supporting Automatic Repeat reQuest (ARQ) method. In particular, the present invention discloses scheduling a data unit transmitted to a mobile station from a base station providing ARQ method for correcting an error in wireless data communication and generating a high rate frame.According to the present invention, there is provided a transmission controlling apparatus comprising a receiver to receive mobile station status information from a mobile station connected with a base station, a schedule managing unit to determine transmission priority of a plurality of data units to be transmitted to the mobile station based on the received mobile station status information, and a transmitter to transmit the data units to the mobile station based on the determined transmission priority.

    摘要翻译: 本发明涉及一种支持自动重复请求(ARQ)方法的基站的调度装置。 特别地,本发明公开了一种从提供用于校正无线数据通信中的错误并生成高速率帧的ARQ方法的基站调度发送到移动台的数据单元。 根据本发明,提供了一种传输控制装置,包括:接收器,用于从与基站连接的移动台接收移动台状态信息;调度管理单元,用于确定要发送的多个数据单元的传输优先级 基于接收到的移动台状态信息的移动站,以及基于所确定的传输优先级向移动站发送数据单元的发射机。

    ANTICANCER AGENT COMPRISING ANTI-PD-1 ANTIBODY OR ANTI-PD-L1 ANTIBODY
    6.
    发明申请
    ANTICANCER AGENT COMPRISING ANTI-PD-1 ANTIBODY OR ANTI-PD-L1 ANTIBODY 有权
    包含抗PD-1抗体或抗PD-L1抗体的抗体试剂

    公开(公告)号:US20120237522A1

    公开(公告)日:2012-09-20

    申请号:US13398915

    申请日:2012-02-17

    摘要: Provided is an anticancer agent which comprises an anti-PD-1 antibody or an anti-PD-L1 antibody as an active ingredient, functioning to reverse the unresponsiveness of iNKT cells in which anergy has been induced by administration with an iNKT cell ligand. The anti-PD-1 or anti-PD-L1 antibody blocks the PD-1/PD-L1-mediated signaling pathway not only to prevent the iNKT cell ligand-induced iNKT cell anergy, but also to reverse the unresponsiveness of already anergic iNKT cells to produce cytokines. In addition, the anti-PD1 or anti-PD-L1 antibody ensures the potent anti-tumor activity of iNKT cells as demonstrated by a significant reduction in the number of metastatic nodules in B16F10 melanoma metastasis models in vivo. Collectively, the anticancer agent can be very useful in the treatment of cancer, particularly metastatic cancer.

    摘要翻译: 提供一种抗癌剂,其包含抗PD-1抗体或抗-PD-L1抗体作为活性成分,其功能是通过用iNKT细胞配体施用而逆转已经诱导了无能力的iNKT细胞的无反应性。 抗PD-1或抗PD-L1抗体阻断PD-1 / PD-L1介导的信号通路,不仅可以防止iNKT细胞配体诱导的iNKT细胞无反应,而且可以逆转已经无能的iNKT的无反应性 细胞产生细胞因子。 此外,抗PD1或抗PD-L1抗体确保iNKT细胞的有效的抗肿瘤活性,如通过体内B16F10黑素瘤转移模型中转移性结节数量的显着减少所证实的。 总的来说,抗癌剂在治疗癌症,特别是转移性癌症中是非常有用的。